Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, has appointed Elaine Sun as chief operating officer (COO) and chief financial officer (CFO).   “We’re delighted to welcome Elaine to our growing team, as we realize our mission of bringing forth the next generation of CRISPR-based diagnostics and therapeutics,” said Trevor Martin, co-founder and chief executive officer of Mammoth Biosciences. “She brings with her the strategic, op...